Zaccaria, Gian Maria
 Distribuzione geografica
Continente #
NA - Nord America 2.867
EU - Europa 2.219
AS - Asia 1.489
SA - Sud America 457
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 39
OC - Oceania 1
Totale 7.160
Nazione #
US - Stati Uniti d'America 2.763
RU - Federazione Russa 1.403
SG - Singapore 486
BR - Brasile 381
IT - Italia 369
CN - Cina 312
VN - Vietnam 201
HK - Hong Kong 127
KR - Corea 87
BD - Bangladesh 76
FR - Francia 71
JP - Giappone 63
SE - Svezia 62
DE - Germania 58
CA - Canada 51
GB - Regno Unito 47
FI - Finlandia 46
NL - Olanda 38
IE - Irlanda 31
AR - Argentina 26
IN - India 24
AT - Austria 22
MX - Messico 19
PL - Polonia 19
ES - Italia 18
TR - Turchia 17
EC - Ecuador 15
IQ - Iraq 15
ZA - Sudafrica 13
ID - Indonesia 12
CO - Colombia 9
CR - Costa Rica 9
UZ - Uzbekistan 8
CL - Cile 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
JO - Giordania 6
LT - Lituania 6
PE - Perù 6
PK - Pakistan 6
AZ - Azerbaigian 5
GT - Guatemala 5
MA - Marocco 5
UA - Ucraina 5
VE - Venezuela 5
AM - Armenia 4
BZ - Belize 4
GE - Georgia 4
GR - Grecia 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
MY - Malesia 4
NP - Nepal 4
SA - Arabia Saudita 4
DZ - Algeria 3
HN - Honduras 3
LB - Libano 3
PY - Paraguay 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
KH - Cambogia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
DK - Danimarca 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.073
Città #
Dallas 1.115
Moscow 315
Singapore 285
Council Bluffs 182
San Jose 164
Ashburn 133
Hong Kong 122
The Dalles 99
Rome 96
New York 95
Hefei 83
Seoul 82
Santa Clara 67
Ho Chi Minh City 66
Tokyo 60
Lauterbourg 52
Boardman 50
Hanoi 50
Los Angeles 46
Bari 40
Kent 39
Helsinki 35
São Paulo 33
Conversano 32
Dublin 30
Amsterdam 29
Phoenix 29
Beijing 27
Denver 24
Milan 22
West Jordan 20
Frankfurt am Main 18
Ogden 17
Warsaw 17
Washington 16
Orem 15
Poplar 15
Rio de Janeiro 15
Montreal 14
Boston 13
Chicago 13
Vienna 13
Düsseldorf 12
Brooklyn 11
Johannesburg 11
Houston 10
Munich 10
Toronto 10
Atlanta 9
Chennai 9
Da Nang 9
Porto Alegre 9
Princeton 9
San José 9
Nuremberg 8
Zola Predosa 8
Campinas 7
Fasano 7
Lappeenranta 7
London 7
Mexico City 7
Miami 7
Naples 7
San Francisco 7
Tashkent 7
Turin 7
Amman 6
Assago 6
Belo Horizonte 6
Brasília 6
Chandler 6
Hillsboro 6
Molfetta 6
Quito 6
Ankara 5
Baku 5
Biên Hòa 5
Catania 5
Caxias do Sul 5
Haiphong 5
Manchester 5
Ninh Bình 5
Osan 5
Osasco 5
Philadelphia 5
Seattle 5
Athens 4
Baghdad 4
Calgary 4
Can Tho 4
Curitiba 4
Dubai 4
Guangzhou 4
Guatemala City 4
Hải Dương 4
Lima 4
Madrid 4
Nairobi 4
Portsmouth 4
Ribeirão Preto 4
Totale 4.056
Nome #
Highly reliable personalized noninvasive hemoglobin estimation by using Vision Transformers and dual fine-tuning 848
A multimodal framework for assessing the link between pathomics, transcriptomics, and pancreatic cancer mutations 248
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 187
Validation of Argo (Automatic record generator for Onco-Hematology), a New App Supporting the Automatic Conversion of Paper-Based Pathology Reports in Standardized Ecrfs 185
A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PROGNOSTICATORS IN MANTLE CELL LYMPHOMA: RESULTS FROM THE MCL0208 TRIAL FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) 185
Development and validation of a machine learning prognostic model based on an epigenomic signature in patients with pancreatic ductal adenocarcinoma 180
Primary, bilateral and diffuse renal non‐hodgkin’s lymphoma in a young woman suffering from turner syndrome 174
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the FIL MCL0208 trial 174
A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants 174
A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma 173
Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification 172
Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients 168
A time-dependent explainable radiomic analysis from the multi-omic cohort of CPTAC-Pancreatic Ductal Adenocarcinoma 162
ARGO 2.0: a Hybrid NLP/ML Framework for Diagnosis Standardization 162
The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 162
Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset 159
IgM-Gammopathies Transformed into Aggressive Lymphoma: Incidence, Basal Clinical Features and Outcome of a Registry Based, Spanish Retrospective Series 156
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma 153
P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERTOIRE IN MANTLE CELL LYMPHOMA: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III MCL0208 TRIAL 150
Dissecting MRD Kinetics By Automated Computational Analysis to Improve Outcome Prediction in Mantle Cell Lymphoma: A Bioinformatic Substudy from the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial 149
A new ensemble method for detecting anomalies in gene expression matrices 139
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival 137
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology 136
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma 134
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer 129
SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data 125
An Approach Based on Process Modeling for Implementing a Health Information Technology in Clinical Practice 124
Data quality improvement of a multicenter clinical trial dataset 121
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical HL-like or PMBL-like subtypes 121
Unraveling MRD Dynamics to Enhance Outcome Prediction in Mantle Cell Lymphoma—Insights from the Fondazione Italiana Linfomi MCL0208 Clinical Trial 119
Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study) 118
Development and validation of a simplified score to predict early relapse in newly diagnosed multiple myeloma in a pooled dataset of 2,190 patients 115
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes 111
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial 103
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 101
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network 100
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 99
Multimodal framework for TACE treatment response prediction in patients with hepatocellular carcinoma 99
Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 90
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 90
ZebraBeat : A flexible platform for the analysis of the cardiac rate in zebrafish embryos 88
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 87
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML 86
Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute: Experience of the Cancer Institute of Bari 86
Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL) 82
Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma 77
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy 54
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial 43
Pharmacokinetic-pharmacodynamic modeling of tumor angiogenesis unveils the need for time-adjustable drug regimens 39
Development and independent validation of explainable radiomics-based machine learning models for prognosis in colorectal liver metastases 35
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study 17
Dengue virus serotype classification from complete genomes using a Transformer with chunk-based sequence modeling and explainability analysis 14
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)‐MCL0208 clinical trial 11
A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell‐of‐Origin Assignment of Diffuse Large B‐Cell Lymphoma 9
Totale 7.160
Categoria #
all - tutte 21.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 1 3
2022/2023145 1 0 0 2 1 3 0 2 11 107 15 3
2023/2024406 32 17 18 10 104 98 5 0 29 34 1 58
2024/20251.021 19 6 91 8 52 27 58 66 192 160 240 102
2025/20265.051 115 503 1.047 569 255 448 918 563 126 170 181 156
2026/2027533 55 118 230 130 0 0 0 0 0 0 0 0
Totale 7.160